First National Bank of Mount Dora Trust Investment Services boosted its holdings in shares of Linde plc (NASDAQ:LIN – Free Report) by 9.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,217 shares of the basic materials company’s stock after acquiring an additional 1,283 shares during the period. Linde accounts for about 1.5% of First National Bank of Mount Dora Trust Investment Services’ investment portfolio, making the stock its 22nd largest holding. First National Bank of Mount Dora Trust Investment Services’ holdings in Linde were worth $6,780,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the business. Trifecta Capital Advisors LLC increased its position in shares of Linde by 16.9% during the third quarter. Trifecta Capital Advisors LLC now owns 145 shares of the basic materials company’s stock valued at $69,000 after acquiring an additional 21 shares in the last quarter. Prentice Wealth Management LLC increased its holdings in shares of Linde by 1.7% in the 3rd quarter. Prentice Wealth Management LLC now owns 1,367 shares of the basic materials company’s stock worth $652,000 after purchasing an additional 23 shares in the last quarter. Quotient Wealth Partners LLC raised its stake in shares of Linde by 0.9% in the third quarter. Quotient Wealth Partners LLC now owns 2,706 shares of the basic materials company’s stock worth $1,290,000 after purchasing an additional 23 shares during the last quarter. Regent Peak Wealth Advisors LLC lifted its holdings in shares of Linde by 1.3% during the third quarter. Regent Peak Wealth Advisors LLC now owns 1,831 shares of the basic materials company’s stock valued at $873,000 after purchasing an additional 23 shares in the last quarter. Finally, Nwam LLC boosted its position in shares of Linde by 2.5% during the first quarter. Nwam LLC now owns 966 shares of the basic materials company’s stock valued at $421,000 after buying an additional 24 shares during the last quarter. Institutional investors own 82.80% of the company’s stock.
Wall Street Analysts Forecast Growth
LIN has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. boosted their target price on Linde from $430.00 to $480.00 and gave the stock an “overweight” rating in a research report on Monday, August 5th. Bank of America increased their price objective on shares of Linde from $495.00 to $516.00 and gave the company a “buy” rating in a research report on Monday, August 5th. Mizuho raised their target price on shares of Linde from $520.00 to $530.00 and gave the stock an “outperform” rating in a report on Friday. Deutsche Bank Aktiengesellschaft raised their target price on Linde from $510.00 to $515.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Barclays lifted their price target on shares of Linde from $460.00 to $510.00 and gave the stock an “overweight” rating in a research note on Monday, August 5th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $490.75.
Linde Price Performance
LIN traded up $3.36 during trading hours on Monday, hitting $460.67. The company’s stock had a trading volume of 181,015 shares, compared to its average volume of 1,826,948. Linde plc has a 12 month low of $385.12 and a 12 month high of $487.49. The company has a current ratio of 0.96, a quick ratio of 0.80 and a debt-to-equity ratio of 0.43. The business’s 50-day moving average price is $472.87 and its 200-day moving average price is $451.90. The stock has a market cap of $219.97 billion, a price-to-earnings ratio of 34.72, a P/E/G ratio of 2.89 and a beta of 0.94.
Linde (NASDAQ:LIN – Get Free Report) last announced its earnings results on Thursday, October 31st. The basic materials company reported $3.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.89 by $0.05. The firm had revenue of $8.36 billion for the quarter, compared to analysts’ expectations of $8.39 billion. Linde had a net margin of 19.33% and a return on equity of 18.16%. The business’s revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the company earned $3.63 EPS. Sell-side analysts expect that Linde plc will post 15.52 earnings per share for the current fiscal year.
Linde Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Tuesday, December 3rd will be given a dividend of $1.39 per share. This represents a $5.56 annualized dividend and a dividend yield of 1.21%. The ex-dividend date is Tuesday, December 3rd. Linde’s dividend payout ratio is currently 42.22%.
Insider Buying and Selling
In other Linde news, VP John Panikar sold 10,025 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $462.75, for a total transaction of $4,639,068.75. Following the transaction, the vice president now owns 17,584 shares in the company, valued at $8,136,996. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.60% of the stock is owned by corporate insiders.
Linde Company Profile
Linde plc operates as an industrial gas company in the Americas, Europe, the Middle East, Africa, Asia, and South Pacific. It offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Featured Stories
- Five stocks we like better than Linde
- Investing In Preferred Stock vs. Common Stock
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Stocks That Are Potential Takeover Targets in 2025
Want to see what other hedge funds are holding LIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Linde plc (NASDAQ:LIN – Free Report).
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.